Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Achaogen Common Stock Offering
Davis Polk advised the joint book-running managers in connection with the $112.5 million public offering of common…
Alnylam Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised the sole book-running manager of a $359.35 million SEC-registered offering of 5,000,000 shares of common…
Evolent Health, Inc. Common Stock Secondary Offering
Davis Polk advised the representative of the several underwriters in connection with a secondary offering of 7,000,000…
DexCom, Inc. $350 Million Convertible Notes Offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by DexCom, Inc. of $350 million…
AMAG Pharmaceuticals, Inc. $300 Million Convertible Senior Notes Offering
Davis Polk advised the underwriters in connection with an SEC-registered offering by AMAG Pharmaceuticals, Inc. of $300…
Eli Lilly $2.25 Billion Notes Offering
Davis Polk advised the joint book-running managers in connection with a $2.25 billion registered offering by Eli Lilly…
Flexion Therapeutics $201.25 Million Convertible Senior Notes Offering
Davis Polk advised the representative of the initial purchasers in a Rule 144A offering by Flexion Therapeutics, Inc. of …
Agios Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the…
Galapagos NV €363.9 Million Follow-On Offering of American Depositary Shares
Davis Polk advised the sole book-running manager in connection with Galapagos NV’s offering of 4,312,500 ordinary shares in…
Abbott and Alere Amend Merger Agreement
Davis Polk is advising J.P. Morgan as financial adviser to Alere Inc. in connection with the amendment of the existing terms…